MLC901 may be effective in treatment of post-concussion symptoms in phase III study
1. MLC901 significantly improved post-concussion symptoms, quality of life, and mood at 6 and 9 months. 2. MLC901 was safe ...
1. MLC901 significantly improved post-concussion symptoms, quality of life, and mood at 6 and 9 months. 2. MLC901 was safe ...
1. Gabapentin use was associated with a 29% increased risk of dementia and 85% increased risk of mild cognitive impairment ...
1. Newer-generation antiseizure medications (ASMs) were better tolerated and more likely to be maintained than older ASMs. 2. Only 23% ...
1. Thrombolysis-to-puncture time (TTP) >70 minutes significantly reduces the odds of successful recanalization and 90-day functional independence. 2. There was ...
1. Type 2 diabetes and abnormal amyloid-β concentration (low Aβ42:Aβ40 ratio) in the cerebrospinal fluid were associated with accelerated brain ...
Predictors and outcomes associated with prolonged hospital length of stay in intracerebral hemorrhage: a multicenter prospective cohort study in China ...
1. Among adult patients with migraine headaches, the use of a prescribed digital health app did not reduce the number ...
1. In elderly patients 65 years of age or older with heart failure with reduced ejection fraction (HFrEF), regular use ...
1. In patients with myasthenia gravis (MG) who had anti-acetylcholine receptor antibodies or anti-muscle-specific kinase antibodies, intravenous inebilizumab reduced disease ...
1. In this randomized trial, the use of cerebral embolic protection (CEP) did not decrease the 72-hour incidence of stroke ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.